大鼠运动应激性溃疡的实验研究

对SD大鼠力竭性运动所致应激性胃溃疡进行了观察。并对其可能机制和防治措施进行了探讨。结果：大鼠力竭性游泳运动可导致胃粘膜产生应激性溃疡，运动后24小 时溃疡消失。应激性溃疡的产生是由于攻击因子和防御因子失衡，尤其是防御因子的降低所致。复方丹参注射液对其具有防治作用。     

理气活血中药对运动训练小鼠某些生化指标的影响

观察了理气活血中药对训练小鼠某些生化指标的影响，结果表明：1）服药结合训练能使小鼠肝脏、股四头肌SOD活性明显提高，MDA含量相应减少。提示：服药能改善体内自由基代谢。2）服药结合训练能提高血红蛋白含量，并能降低运动后即刻血尿素水平。3）服药结合训练能使血清GOP活性降低，GTP、ALP呈下降趋势，说明服药对维持细胞完整性有积极作用。4）服用理气活血中药结合训练能使小鼠安静时肝脏、股四头肌LDH活性及运动后即刻肝脏MDH、LDH活性提高。预示机体有关代谢能力加强。5）单纯训练及服药结合训练均能提高肌糖原贮量，并且服药结合训练使运动中肌糖原消耗相对减少，有利于增强耐力。     

46例幽门螺杆菌相关性十二指肠溃疡治疗分析

对４６例幽门螺杆菌相关性十二指肠溃疡给予羟氨苄青霉素、灵滴灵、痢特灵以及雷尼替丁联合治疗，观察６个月，溃疡愈合率达８４．７％，幽门螺杆菌根除率７３．９％，幽门螺杆菌根除组溃疡愈合率９４．１％，明显视于未消除组。     

对兴奋剂定义的探究

运用文献资料法、归纳法等方法对兴奋剂的定义进行研究后认为,兴奋剂在早期是一个约定俗成的概念,给兴奋剂下一个内涵确切的定义具有一定的困难.国际奥委会和世界反兴奋剂机构从外延角度对"使用兴奋剂"进行界定,并随实践发展对"使用兴奋剂"进行重新界定.通过对兴奋剂定义作补充说明以加深人们对兴奋剂的理解.最后,针对兴奋剂概念的界定提出一些看法.     

联合应用抗精神病药物致恶性综合征1例分析

目的:了解抗精神病药物所致恶性综合征(NMS)的临床特征并探讨NMS发生的影响因素。方法:对某院1例恶性综合征患者病例资料进行分析并复习相关文献资料。结果:抗精神病药物所致NMS男多于女,青壮年居多,传统抗精神病药物与多种抗精神病药物联用、增加剂量过快是产生NMS的危险因素。结论:NMS病情凶险,死亡率高,临床上要认真评估抗精神病药物应用指征,综合考虑患者的个体素质、营养、躯体及精神征状等多种因素来选用抗精神病药物,使用中密切观察病人耐受性,缓慢增加药物剂量,特别是对精神发育迟滞患者、老年患者、有器质性病变及夏季应用吩噻嗪类药物的患者应仔细观察,减少危险因素,有效预防NMS。     

荧光光谱法研究喹诺酮类药物的进展

本文对近几年来使用各种不同的荧光分析方法对不同喹诺酮药物的各方面进行研究的进展情况进行了综述,说明了喹诺酮类药物重要的反应体系和荧光分析特性,为进一步研究喹诺酮类药物提供了参考.     

Antioxidant activity of ethanol extract of rhizome ofPicrorhiza kurroa on indomethacin induced gastric ulcer during healing

Oral administration of ethanol extract of the rhizome ofPirorhiza kurroa at a dose of 20mg/kg body weight, for 10 consecutive days, was found to enhance the rate of healing on Indomethacin-induced gastric ulcer in rats, compared to the ulcerated group without treatment. The level of peroxidised lipid, in terms of thiobarbituric acid reactive species (TBARS), in gastric tissue, was increased in ulcerated rats which was restored to near normalcy on treatment with ethanol extract. The specific activity ofin vivo antioxidant enzymes, viz SOD and catalase and total tissue sulfhydryl (thiol) group, which were markedly decreased in ulcerated group, were found to be significantly elevated (p<0.05), on treatment with the above extract, at the specified dose, compared to the indomethacin—induced ulcerated group without any supporting treatment. The present study thus suggests that the ethanol extract of rhizome ofPicrorhiza kurroa, at the dose of 20mg/kg body weight, accelerated the healing of stomach wall of indomethacin induced gastric ulcerated rats by anin vivo free radical scavenging action.     

身痛逐瘀汤对比非甾体类抗炎药治疗腰椎间盘突出症META-分析

目的:对比身痛逐瘀汤加减与非甾体类抗炎药治疗腰椎间盘突出症的临床疗效。方法:检索维普资讯中文科技期刊数据库、CNKI中国期刊全文数据库,万方医学网数据库等。将符合纳入标准的7篇文献、774位患者的临床疗效进行Meta-分析。Meta-分析的软件为Cochrane协作网免费提供的Revman5.2专用软件。结果:提示身痛逐瘀汤治疗腰椎间盘突出症比非甾体类抗炎药治疗腰椎间盘突出症临床疗效好。结论:纳入资料Meta-分析后,同等基础条件下,治疗组中加入身痛逐瘀汤加减,对照组中加入单一或多种非甾体类抗炎药,治疗组可以显著提高治疗腰椎间盘突出症的有效率。     

门诊和住院病人抗高血压药物用药情况及依从性调查

目的：为探讨高血压住院和门诊患者降压药物的依从性及其相关因素；了解降压药物的用药情况。方法：回顾性分析1997年12月至2001年10月高血压病住院患者408例和门诊随访患者249例的降压药物依从性及其相关因素；调查降压药物的使用情况和药物副作用的发生率；观察药物依从者和不依从者的血压水平变化。结果：高血压住院病人的心血管危险因素，住院期间的药物依从率为63．5％，出院时出院药的依从率77．1％，门诊随访期间的药物依从性为43．4％，结论：出院后对出院带药的依从性最佳，住院期间的药物依从性次之，门诊随访期间的药物从性最差，门诊随访期间钙拮抗剂和利尿剂的副作用明显增多，药物依从者血压的波动小，药物不依从者血压的波动大。     

Additive Effect of Lipid Lowering Drug (Simvastatin) in Combination with Antidiabetic Drug (Glibenclamide) on Alloxan Induced Diabetic Rats with Long Term Dyslipidemia

High blood glucose level, elevated level of liver enzyme, necrosis and shrinkage of islets of Langerhans has been implicated in the pathogenesis of type 2 diabetes. High blood glucose cause oxidative stress, production of free radical as well as elevated SGPT and SGOT level. Both glibenclamide and simvastatin in fixed dose used as antihyperglycemic antidyslipidemic and antioxidative agents for type 2 diabetes treatment. This study therefore aimed to evaluate the antihyperglycemic, antidyslipidemic and antioxidative effect of fixed dose combination of glibenclamide (0.6 mg/70 kg body weight) and simvastatin (5 mg/70 kg body weight) on long term alloxan induced diabetic rats with cardiovascular disease using various diagnostic kits as a parameter of phamacotherapeutic and pharmacological effect. The study was carried out using 96 Swiss Albino male rats weighing about 200–220 g. Combination therapy induced a significant decrease in blood glucose level in alloxan induced diabetic rats, from 33.75 ± 1.65 to 5.80 ± 0.07 mmol/l 2 h after last dose administration, after 4 weeks treatment. In case of dyslipidemic effect, combination therapy reduced total cholesterol (45 %), triglyceride (36 %) and low density lipoprotein-cholesterol (32 %) levels significantly and increased high density lipoprotein-cholesterol level (57 %) in comparison with their respective diabetic control groups. Results of this study showed that combination therapy effectively decreased SGPT (ALAT) (55 %) and SGOT (ASAT) (51 %) in comparison with diabetic control group. It was also observed that catalase and superoxide dismutase enzyme activity was increased by 58 and 91 % respectively in comparison with diabetic control group after 4 weeks treatment with combination of both drugs. In conclusion, these findings of combination therapy (glibenclamide and simvastatin) on alloxan induced diabetes in rats are significantly better than monotherapy using single drug. The results of the present study suggest that, combination of the fixed dose of glibenclamide and simvastatin might be efficacious in patients with diabetic dyslipidemia and increased oxidative stress. Furthermore, this combination therapy offer dosage convenience to the patients and by virtue of its dual mode of action might be a useful addition to the therapeutic armamentarium for patients with diabetic dyslipidemia and oxidative stress.